# US 2021/0228479 A1 · Steroidal compositions and method of making and use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228479 A1
- Document ID: US20210228479A1
- Status: Published application
- Kind: A1
- Application number: 17/162,549
- Filed: 2021-01-29
- Published: 2021-07-29
- Earliest claimed: 2020-01-29
- Assignees: FarmaKeio Nutraceuticals, LLC
- Applicants: Farmakeio Nutraceuticals LLC
- Inventors: Cody Boatman; Daniel DeNeui
- Web page: https://patentgrep.com/patent/US20210228479A1

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61K 9/282: {Organic compounds, e.g. fats}
- A61K 31/568: substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed herein are compositions suitable for use in increasing the energy level, memory function and cognitive focus, and lowering the feeling of lethargy in men and women. Further disclosed are methods of use and processes for preparing the disclosed compositions.

## Claims

### Claim 1

An implantable pharmaceutical composition, comprising:
a) from about 90% to about 99% by weight of testosterone:
b) from about 0.005% to about 0.05% by weight of triamcinolone; and
c) the balance carriers and adjunct ingredients;
wherein the composition is in the form of a pellet having a hardness of at less than about 75 Newtons.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 92% to about 99% by weight of testosterone.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 90% to about 97% by weight of testosterone.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 93% to about 99% by weight of testosterone.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 90% to about 96% by weight of testosterone.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 93% to about 97% by weight of testosterone.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the composition comprises 95% by weight of testosterone.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 0.0075% to about 0.05% by weight of triamcinolone.

### Claim 9 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 0.005% to about 0.04% by weight of triamcinolone.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 0.01% to about 0.04% by weight of triamcinolone.

### Claim 11 (depends on 1)

The composition according to claim 1, wherein the composition comprises from about 0.015% to about 00.3% by weight of triamcinolone.

### Claim 12 (depends on 1)

The composition according to claim 1, wherein the composition comprises 0.02% by weight of triamcinolone.

### Claim 13 (depends on 1)

The composition according to claim 1, comprising about 4% by weight of a coating agent.

### Claim 14 (depends on 13)

The composition according to claim 13, wherein the coating agent is chose from dextran, poly(ε-caprolactone), poly(1,4-dioxan-2-one), poly(sebacic anhydride), poly(dodecanoic anhydride), poly(ethylene glycol), polyoxyethylene, stearic acid, stearyl alcohol, ethylene glycol palmitostearate, cetyl esters wax, poly(1,3-bis(carboxyphenoxy)propane-co-sebacic acid), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or a combination thereof.

### Claim 15 (depends on 13)

The composition according to claim 13, wherein the coating agent is stearic acid or stearyl alcohol.

### Claim 16 (depends on 13)

The composition according to claim 13, wherein the coating agent is stearic acid.

### Claim 17 (depends on 1)

The composition according to claim 1, further comprising a binding agent.

### Claim 18 (depends on 17)

The composition according to claim 17, wherein the binding agent is chosen from polyethylene glycol 1500, polyethylene glycol 2000, polyethylene glycol 3000, polyethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 8000, polyethylene glycol 10000, methylcellulose, ethylcellulose, hydroxymethyl cellulose, hydroxyethylcellulose, hydroxypropyl methylcellulose, polyoxyethylene, copolymers of polyoxyethylene-polyoxypropylene and mixtures thereof.

### Claim 19 (depends on 18)

The composition according to claim 18, wherein the binding agent is methylcellulose, ethylcellulose, hydroxymethyl cellulose, or hydroxyethylcellulose.

### Claim 20 (depends on 18)

The composition according to claim 18, wherein the binding agent is ethylcellulose.

### Claim at position 21

-55. (canceled)
